PLURI

What this means for you

Approved and waiting on proof of use. It will register unless the applicant drops it, and its 19 Nov 2023 filing date already counts against anyone who files later.

Record

Serial number

79397427

Mark type

Design + words

Filed

19 Nov 2023

Published for opposition

29 Sept 2026

Attorney of record

Alexander Lazouski

Goods and services

• Class 001 — Chemicals: Biological preparations for use in industry and science; bioengineered cells for use in industry and science; bioengineered human T cells for use in industry and science; biological tissue, namely, human and animal cells from placentas for use in industry and science; biological tissue, namely, human and animal cells from placentas for use in the manufacture of cosmetic and aesthetic products; biological tissue, namely, human and animal cells from placentas for use in manufacturing biological cosmetic preparations for prevention of hair loss; isolated plant cells, their extracts, and components being botanical extracts, other than essential oils, for use in industry and science; biological tissue, namely, isolated and cultivated adherent cells from placenta tissue for use industry and science; biological tissue, namely, isolated and cultivated adherent stromal cells derived from placentas of multiple donors for use in industry and science; biological tissue, namely, isolated and cultivated mammal cells, their extracts and components for use in industrial manufacture of foodstuffs; biological tissue, namely, isolated and cultivated fish cells and sea food being marine animal cells for use in industrial manufacture of foodstuffs; biological tissue, namely, isolated and cultivated plant cells and their extracts, other than essential oils, for use in industrial manufacture of foodstuffs
• Class 005 — Pharmaceuticals: Cells and biological preparations intended for medical and clinical use for the treatment of cardiovascular diseases, Critical Limb Ischemia (CLI), muscle regeneration, Acute Radiation Syndrome (ARS), Delayed Effects of Acute Radiation Exposure (DEARE), hematological deficiencies, and pathogenic infectious diseases; bioengineered cells and bioengineered tissue for medical and clinical use for the treatment of cancer; bioengineered cells for use in immunotherapies for treatment of cancer in the nature of solid tumors, and pathogenic infectious diseases; bioengineered human T cells for medical and clinical use; human cells from placentas for medical and clinical use; dietary supplements based on human cells from placentas for cosmetic and aesthetic use; dietary supplements and medical preparations based on human cells from placentas for use in prevention of hair loss; isolated plant cells, their extracts and components being plant extracts, other than essential oils, for medical and clinical use; isolated and cultivated adherent cells from placenta tissue for medical and clinical use; isolated and cultivated adherent stromal cells derived from placentas of multiple donors for medical and clinical use; isolated and cultivated plant cells, their extracts and components being plant extracts, other than essential oils, for medical and clinical use and preparations containing the same for the treatment of inflammatory skin conditions, skin regeneration following burns and environmental damage, for wound healing, for treating arthritis, for maintaining and supporting gut health, for boosting immunity, and for improving general energy levels
• Class 042 — Scientific and technological services: Scientific and technological services, namely, scientific research relating to isolation and culturing of animal cells and plant cells and to animal and plant tissues isolation and culturing, to biological preparations intended for medical, clinical, and scientific use of cultured cells and their extracts, to bioengineered cells and tissues, to bioengineered cells for use in immunotherapy for cancer and other infectious diseases, to bioengineered human T cells, to isolated and cultivated human and animal placentas cells, to isolated plant cells and their extracts, to isolated and cultivated adherent cells from placenta tissue, to isolated and cultivated adherent stromal cells derived from placentas of multiple donors, to isolated and cultivated mammal cells, their extracts and preparations containing them, to isolated and cultivated fish cells and sea food cells and preparations containing the same, to isolated and cultivated plant cells and their extracts and preparations containing the same, to research, development and testing services in the fields of mass production of animal and plant cells, and to research, development and testing services in the fields of large scale production of various cells in bioreactors

Owner

• PLURI BIOTECH LTD, IL

Prosecution history

• 02 Sept 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
• 04 Aug 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
• 04 Aug 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
• 04 Aug 2026 — TEAS REQUEST FOR RECONSIDERATION RECEIVED
• 28 Jul 2026 — NOTIFICATION OF FINAL REFUSAL EMAILED
• 28 Jul 2026 — FINAL REFUSAL E-MAILED
• 28 Jul 2026 — FINAL REFUSAL WRITTEN
• 30 May 2026 — SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
• 30 Nov 2025 — NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
• 20 Nov 2025 — REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
• 12 Nov 2025 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
• 12 Nov 2025 — NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
• 19 May 2025 — NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
• 19 May 2025 — LETTER OF SUSPENSION E-MAILED
• 19 May 2025 — SUSPENSION LETTER WRITTEN